CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Accounts Receivable, Allowance for Credit Loss
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Accounts Receivable, Allowance for Credit Loss of $8.71 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-05
- 2026-06-27: Accounts Receivable, Allowance for Credit Loss $8.71M.
- 2026-03-28: Accounts Receivable, Allowance for Credit Loss $8.11M.
- 2025-12-27: Accounts Receivable, Allowance for Credit Loss $10.46M.
- 2025-09-27: Accounts Receivable, Allowance for Credit Loss $13.80M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-27 | $8.71M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $8.11M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $10.46M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $13.80M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $12.84M 10-Q · filed 2026-08-05 |
| 2025-03-29 | $16.26M 10-Q · filed 2026-05-07 |
| 2024-12-28 | $18.30M 10-Q · filed 2026-08-05 |
| 2024-09-28 | $23.88M 10-Q · filed 2025-11-05 |
| 2024-06-29 | $24.95M 10-Q · filed 2025-08-06 |
| 2024-03-30 | $25.41M 10-Q · filed 2025-05-07 |
| 2023-12-30 | $25.72M 10-K · filed 2026-02-18 |
| 2023-09-30 | $21.19M 10-Q · filed 2024-11-06 |
| 2023-07-01 | $18.04M 10-Q · filed 2024-08-07 |
| 2023-04-01 | $16.69M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $11.28M 10-K · filed 2026-02-18 |
| 2021-12-25 | $7.18M 10-K · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |